Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 1

Interventions

Adalimumab 10 Etanercept 9 Methotrexate 4 Infliximab 3 tofacitinib 2 Rituximab 2 Leflunomide 2 Abatacept 2 tocilizumab 1 sarilumab 1 golimumab 1 entecavir 1 Tumor Necrosis Factor Inhibitors 1 Sulfasalazine 1 Prednisone 1 Licensure 1 Hydroxychloroquine 1 Glucocorticoids 1 Folic Acid 1 Chloroquine 1 Certolizumab Pegol 1 Azathioprine 1 Antirheumatic Agents 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Arthritis, Rheumatoid × Certolizumab Pegol × Clear all

NCT01295151 2016-11-02

SWITCH

University of Leeds

Phase 4 Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡